David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
IMPORTANT: Labor & Delivery services have moved from Temple University Hospital–Main Campus (Broad & Ontario) to our new women & families hospital.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Anjali Vaidya Offers Insight to Healio on HYPERION Trial Findings, Study of Sotatercept in Pulmonary Arterial Hypertension Within One Year of Diagnosis
Posted October 9, 2025Anjali Vaidya, MD, FACC, FASE, FACP, Director of the Advanced Pulmonary Hypertension, Right Heart Failure and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program at Temple University Hospital, offered insight to Healio on findings from the HYPERION trial.
Read MoreDr. William Van Decker Joins Pharmacy Times’ Podcast to Discuss ACC Legislative Conference
Posted October 9, 2025
William Van Decker, MD, Professor of Medicine at the Lewis Katz School of Medicine at Temple University, joined the Pharmacy Times’ “Pharmacy Focus” podcast to discuss the major themes of the upcoming American College of Cardiology’s (ACC) Legislative Conference.